|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
|
dopaminergic agent
A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
NMDA receptor antagonist
Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs.
|
|
|
dopaminergic agent
A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.
antiparkinson drug
A drug used in the treatment of Parkinson's disease.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
|
|
|
3,5-dimethyladamantan-1-amine
|
|
1,3-Dimethyl-5-adamantanamine
|
ChemIDplus
|
|
1-Amino-3,5-dimethyladamantane
|
ChemIDplus
|
|
3,5-Dimethyl-1-adamantanamine
|
NIST Chemistry WebBook
|
|
3,5-Dimethyl-1-aminoadamantane
|
ChEBI
|
|
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
|
ChemIDplus
|
